FDA Drug recall D-0248-2025
Avastin 1.25 mg/0.05 mL in 0.25 mL Syringe, For Intravitreal Injection Only, Office Use Only - Not for Resale - Single Use, This drug produ…
- FDA Drug
- Class II
- completed
- Published 2025-03-05
On 2025-03-05 the FDA classified a Class II recall of Avastin 1.25 mg/0.05 mL in 0.25 mL Syringe, For Intravitreal Injection Only, Office Use Only - Not for Resale - Single Use, This drug produ… by Turbare Manufacturing, citing lack of Assurance of Sterility: due to a quality control process deviation.
Read the official FDA Drug notice
| Agency | FDA Drug |
|---|---|
| Recall number | D-0248-2025 |
| Classification | Class II |
| Status | completed |
| Initiated | 2025-02-18 |
| Published | 2025-03-05 |
| Last updated | 2026-09-13 11:52 UTC |
| Company | Turbare Manufacturing |
| Distribution | US |
Product
Avastin 1.25 mg/0.05 mL in 0.25 mL Syringe, For Intravitreal Injection Only, Office Use Only - Not for Resale - Single Use, This drug product was repackaged by Turbare Manufacturing, 925 Jeanette Drive, Conway, AR 72032, NDC: 83556-0101-01.
Reason
Lack of Assurance of Sterility: due to a quality control process deviation
Identifiers
| code_info | Lot #s: 12122024@2 (BUD: 3/12/2025); 12192024@2 (BUD: 4/18/2025). |
|---|
Status history
No status changes recorded since RecallRadar first saw this recall on 2026-09-13 11:52 UTC. Current status: completed.
Source
Official record: https://api.fda.gov/drug/enforcement.json?search=recall_number:%22D-0248-2025%22
RecallRadar indexes public recall notices from the FDA, USDA FSIS, and CPSC. The official agency notice is the authoritative source. Always confirm details at the linked source before acting.